Phase Forward's DefineValidator tool available for CDISC adopters

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the release of its DefineValidator tool, Release 1.0, as a free download for CDISC adopters.

The tool was adapted from a current feature of Phase Forward’s WebSDM™ product, which was developed under a Cooperative Research and Development Agreement (CRADA) for the FDA to validate and review submission data in CDISC Study Data Tabulation Model (SDTM) format.

The define.xml file is used by the FDA to understand the contents of CDISC SDTM submissions, and is necessary to load clinical study data into the FDA’s Janus data warehouse. Problems with the file can delay loading of submission data into Janus and make it difficult for reviewers to understand SDTM data submissions. Unfortunately, many of these files received to date by FDA have been problematic, partly due to the lack of a widely available validation tool that can be used by most sponsors. Phase Forward’s DefineValidator tool is designed to help sponsors identify and correct define.xml errors prior to submitting to FDA, which should streamline the submission process for both parties.

“We’re very pleased that Phase Forward has contributed this important tool to the standards community,” said David Iberson-Hurst, vice president of technical services for CDISC. “Tools like this will help increase the adoption of CDISC standards among sponsors and help FDA to continue to realize the many benefits of working with CDISC data standards.”

“The free release of this tool underscores Phase Forward’s longstanding commitment to industry standards,” said Steve Rosenberg, senior vice president of products and services for Phase Forward. “As a founding sponsor of CDISC, we want to help ensure the widespread adoption of standards, making the submission process work more smoothly for everyone.”

The DefineValidator tool is currently available for download at http://www.phaseforward.com/products/cdisc/.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk